niacinamide has been researched along with aspirin in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (35.71) | 18.7374 |
| 1990's | 4 (14.29) | 18.2507 |
| 2000's | 2 (7.14) | 29.6817 |
| 2010's | 12 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Franz, TJ | 1 |
| Suzuki, EM | 1 |
| Hosoda, S; Uchida, T | 1 |
| Imamura, I; Wada, H; Watanabe, T | 1 |
| Nakamura, Y; Sakai, K; Sugimoto, T; Yamazaki, T | 1 |
| Houpt, JB; Hunt, M; Ogryzlo, MA | 1 |
| Courtney, KD; Valerio, DA | 1 |
| Fox, IH; Gershon, SL | 1 |
| Gaut, ZN; Solomon, HM | 1 |
| Burke, V; Gracey, M | 1 |
| Hata, S; Koide, T; Matsushita, H; Mizukami, M; Nakano, M; Neichi, T; Noda, Y; Yamazaki, T | 1 |
| Bueno, O; Zavecz, JH | 1 |
| Shetty, K | 1 |
| Du, J; Hoag, SW | 1 |
| DEWHURST, F | 1 |
| Flemming, A; Picker-Freyer, KM | 1 |
| Baek, YH; Cho, JH; Han, JS; Han, SY; Kim, BG; Kim, SO; Lee, SW; Nam, KJ | 1 |
| Kadam, PV; Patil, MJ; Pimple, BP | 1 |
| Boersma-van Ek, W; de Jong, S; de Vries, EG; Hollema, H; Kleibeuker, JH; Kruyt, FA; Pennarun, B | 1 |
| Ao, JY; Chai, ZT; Kong, LQ; Li, JQ; Lu, L; Sun, HC; Tang, ZY; Wang, L; Wang, WQ; Wu, WZ; Zhang, KZ; Zhang, QB; Zhang, W; Zhang, YY; Zhu, XD | 1 |
| Kartashova, EA; Romantsov, MG; Sarvilina, IV | 1 |
| Anisimov, VN; Bazhanova, ED; Sukhanov, DS; Teplyĭ, DL | 1 |
| Chen, J; Jia, H; Lu, L; Lu, M; Pei, Y; Qin, L; Zhu, W | 1 |
| Gao, M; Hua, H; Jiang, Y; Kong, Q; Luo, T; Wang, J; Yin, Y | 1 |
| Jang, H; Kim, EH; Roh, JL; Shin, D | 1 |
| Dai, X; Ding, J; Fu, X; Geng, M; Huang, M; Huang, X; Liu, H; Shen, A; Sun, D; Wei, R; Yan, J; Zheng, X | 1 |
| Chen, K; Dai, W; Fan, X; Feng, J; Guo, C; Li, J; Li, S; Liu, T; Lu, J; Lu, X; Mo, W; Wang, W; Wu, L; Xia, Y; Xu, L; Xu, S; Yu, Q; Zhang, Q; Zhou, Y | 1 |
2 review(s) available for niacinamide and aspirin
| Article | Year |
|---|---|
Pharmacologic therapy of angina pectoris.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Drug Therapy, Combination; Enoximone; Heparin; Humans; Isosorbide Dinitrate; Niacinamide; Nicorandil; Nitroglycerin; Piperazines; Ranolazine; Vasodilator Agents | 1995 |
Prescribing for angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Humans; Myocardial Ischemia; Niacinamide; Nicorandil; Nitrates; Vasodilator Agents | 1994 |
1 trial(s) available for niacinamide and aspirin
| Article | Year |
|---|---|
[The influence of citoflavin on molecular mechanisms of hypertensive encephalopathy development in patients with systolic arterial hypertension].
Topics: Aged; Aged, 80 and over; Amlodipine; Aspirin; Atorvastatin; Blood Pressure; Blood Proteins; Drug Combinations; Drug Therapy, Combination; Echocardiography; Female; Flavin Mononucleotide; Hemodynamics; Heptanoic Acids; Humans; Hypertension; Hypertensive Encephalopathy; Inosine Diphosphate; Male; Neuroprotective Agents; Niacinamide; Pyrroles; Signal Transduction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Succinates; Systole; Tetrazoles; Valine; Valsartan | 2014 |
25 other study(ies) available for niacinamide and aspirin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Percutaneous absorption on the relevance of in vitro data.
Topics: Aspirin; Caffeine; Carbon Radioisotopes; Chloramphenicol; Chlorobenzenes; Hippurates; Humans; In Vitro Techniques; Kinetics; Models, Biological; Niacinamide; Nicotinic Acids; Phenols; Salicylates; Skin Absorption; Thiourea; Urea | 1975 |
Fourier transform infrared analyses of some particulate drug mixtures using a diamond anvil cell with a beam condenser and an infrared microscope.
Topics: Amobarbital; Aspirin; Barbiturates; Caffeine; Chlordiazepoxide; Cocaine; Diphenoxylate; Drug Combinations; Ephedrine; Heroin; Illicit Drugs; Meperidine; Methamphetamine; Niacinamide; Phenacetin; Powders; Secobarbital; Spectrophotometry, Infrared | 1992 |
[Drug therapy of unstable angina].
Topics: Adrenergic beta-Antagonists; Angina, Unstable; Aspirin; Calcium Channel Blockers; Drug Therapy, Combination; Heparin; Humans; Niacinamide; Nicorandil; Nitroglycerin | 1990 |
Formation of N tau-ribosylhistidine, a novel histidine derivative found in the urine in histidinemia, from histidine and NAD(P)+ catalyzed by an NAD(P)+ glycohydrolase system.
Topics: 5'-Nucleotidase; Animals; Aspirin; Histamine; Histidine; Humans; Liver; Magnesium; Magnesium Chloride; NAD+ Nucleosidase; NADP; Niacinamide; Nucleotidases; Pyrophosphatases; Rats | 1985 |
Protective effects of the antianginal agent nicorandil on arachidonate-induced sudden death in rats: comparison with several antianginal agents and cyclooxygenase inhibitors.
Topics: Angina Pectoris; Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Cyclooxygenase Inhibitors; Death, Sudden; Diltiazem; Indomethacin; Male; Mice; Niacinamide; Nicorandil; Nitroglycerin; Rats; Rats, Inbred Strains; Vasodilator Agents | 1985 |
Tryptophan metabolism in man (with special reference to rheumatoid arthritis and scleroderma).
Topics: Arthritis, Rheumatoid; Aspirin; Cystinuria; Drug Synergism; Edetic Acid; Humans; Kynurenic Acid; Kynurenine; Methods; Niacinamide; Penicillamine; Pyridoxine; Scleroderma, Systemic; Tryptophan; Xanthurenates | 1973 |
Teratology in the Macaca mulatta.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Clomiphene; Encephalocele; Female; Fetal Death; Haplorhini; Hydroxyprogesterones; Lincomycin; Meclizine; Methamphetamine; Niacinamide; Penicillin G Benzathine; Penicillin G Procaine; Pregnancy; Syndactyly; Vincristine | 1968 |
Pharmacologic effects of nicotinic acid on human purine metabolism.
Topics: Adult; Aspirin; Creatinine; Erythrocytes; Female; Gout; Humans; Iopanoic Acid; Kidney Tubules; Male; Middle Aged; Niacinamide; Nicotinic Acids; Organophosphorus Compounds; Pentosephosphates; Pentosyltransferases; Phosphoric Acids; Purines; Pyrazinamide; Pyridines; Sulfinpyrazone; Uric Acid | 1974 |
Inhibition of 7- 14 C-nicotinic acid metabolism in the human blood platelet by anti-inflammatory drugs.
Topics: Anti-Inflammatory Agents; Aspirin; Blood Platelets; Carbon Isotopes; Depression, Chemical; Flufenamic Acid; Humans; NAD; NADP; Niacinamide; Nicotinic Acids; Ribonucleotides | 1970 |
Studies with enterotoxigenic microorganisms: effects of candidate antidiarrhoeals in experimental animals in vivo.
Topics: Aluminum Hydroxide; Animals; Antidiarrheals; Aspirin; Bacterial Infections; Charcoal; Chlorpromazine; Cholestyramine Resin; Diarrhea; Drug Combinations; Enterotoxins; Indomethacin; Loperamide; Male; Niacinamide; Rats; Rats, Inbred Strains; Water-Electrolyte Balance | 1984 |
Effects of AVS (1,2-bis(nicotinamido)propane) on platelet function and vascular endothelium.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Blood Vessels; Cerebrovascular Disorders; Collagen; Dinoprostone; Endothelium; In Vitro Techniques; Mice; Microscopy, Electron, Scanning; Niacinamide; Platelet Aggregation; Prostaglandins E; Rabbits; Rats; Rats, Inbred Strains; Thromboembolism; Thrombosis; Thromboxane A2 | 1984 |
The influence of excipients on the stability of the moisture sensitive drugs aspirin and niacinamide: comparison of tablets containing lactose monohydrate with tablets containing anhydrous lactose.
Topics: Aspirin; Drug Stability; Excipients; Lactose; Niacinamide; Tablets; Temperature; Volatilization | 2001 |
THE ATTEMPTED IN VIVO INHIBITION OF THE ORTHO-HYDROXYLATION OF 2-NAPHTHYLAMINE.
Topics: 2-Naphthylamine; Amines; Ascorbic Acid; Aspirin; Carcinogens; Chlorpromazine; Codeine; Dinitrophenols; Enzyme Inhibitors; Fatty Acids; Hydroxylation; Mice; Naphthalenes; Niacinamide; Pyridoxine; Research; Riboflavin; Solvents; Urine | 1963 |
Compaction of lactose drug mixtures: quantification of the extent of incompatibility by FT-Raman spectroscopy.
Topics: Aspirin; Drug Incompatibility; Lactose; Niacinamide; Spectrum Analysis, Raman; Temperature; Thiamine | 2008 |
Splenic infarction associated with sorafenib use in a hepatocellular carcinoma patient.
Topics: Aged; Antineoplastic Agents; Aspirin; Benzenesulfonates; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Sorafenib; Spleen; Splenic Infarction; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Protective effect of Luffa acutangula extracts on gastric ulceration in NIDDM rats: role of gastric mucosal glycoproteins and antioxidants.
Topics: Animals; Antioxidants; Aspirin; Biomarkers; Catalase; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fruit; Gastric Mucosa; Glycoproteins; Luffa; Male; Mice; Niacinamide; Phytotherapy; Plant Extracts; Rats; Stomach Ulcer; Streptozocin; Superoxide Dismutase; Treatment Outcome; Wound Healing | 2012 |
Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAIL.
Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenoma; Antineoplastic Agents; Apoptosis; Aspirin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Drug Therapy, Combination; Gene Knockdown Techniques; Humans; Intestinal Mucosa; Myeloid Cell Leukemia Sequence 1 Protein; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Sorafenib; TNF-Related Apoptosis-Inducing Ligand; Tumor Stem Cell Assay | 2013 |
Aspirin minimized the pro-metastasis effect of sorafenib and improved survival by up-regulating HTATIP2 in hepatocellular carcinoma.
Topics: Acetyltransferases; Animals; Aspirin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Disease Models, Animal; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Hep G2 Cells; Humans; Liver Neoplasms; Male; Mice; Neoplasm Metastasis; Niacinamide; Phenylurea Compounds; Sorafenib; Transcription Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
[Comparative experimental study of the influence of drugs that improve brain metabolism (angiogen, cytoflavin) on neuronal apoptosis and function of cerebral cortex during aging].
Topics: Aging; Animals; Apoptosis; Aspirin; Behavior, Animal; Caspase 3; Caspase 8; Cerebral Cortex; Cognition; Drug Combinations; Flavin Mononucleotide; Gene Expression; Inosine Diphosphate; Mice; Mice, Transgenic; Motor Activity; Motor Neurons; Neuroprotective Agents; Niacinamide; Sensory Receptor Cells; Succinates; Succinic Acid; Tumor Suppressor Protein p53 | 2015 |
Down-regulation of SDF1-α expression in tumor microenvironment is associated with aspirin-mediated suppression of the pro-metastasis effect of sorafenib in hepatocellular carcinoma.
Topics: Animals; Aspirin; Benzylamines; Carcinoma, Hepatocellular; Cell Proliferation; Chemokine CXCL12; Cyclams; Down-Regulation; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Heterocyclic Compounds; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Niacinamide; Phenylurea Compounds; Receptors, CXCR4; Sorafenib; Tumor Microenvironment | 2015 |
AMPK-mediated up-regulation of mTORC2 and MCL-1 compromises the anti-cancer effects of aspirin.
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Apoptosis; Aspirin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasms, Experimental; Niacinamide; Phenylurea Compounds; Sorafenib; TOR Serine-Threonine Kinases; Up-Regulation; Xenograft Model Antitumor Assays | 2016 |
Aspirin plus sorafenib potentiates cisplatin cytotoxicity in resistant head and neck cancer cells through xCT inhibition.
Topics: Amino Acid Transport System y+; Animals; Antioxidants; Apoptosis; Aspirin; Cell Line, Tumor; Cisplatin; DNA Damage; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glutathione; Head and Neck Neoplasms; Humans; Mice; Niacinamide; Phenylurea Compounds; Reactive Oxygen Species; Sorafenib; Xenograft Model Antitumor Assays | 2017 |
Aspirin disrupts the mTOR-Raptor complex and potentiates the anti-cancer activities of sorafenib via mTORC1 inhibition.
Topics: Adaptor Proteins, Signal Transducing; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Aspirin; Carcinoma, Hepatocellular; Cell Proliferation; Cells, Cultured; Drug Therapy, Combination; Embryo, Mammalian; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Knockout; Multiprotein Complexes; Niacinamide; Phenylurea Compounds; Regulatory-Associated Protein of mTOR; Sorafenib; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2017 |
By inhibiting PFKFB3, aspirin overcomes sorafenib resistance in hepatocellular carcinoma.
Topics: Animals; Aspirin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Liver Neoplasms; Mice; Mice, Nude; Niacinamide; Phenylurea Compounds; Phosphofructokinase-2; Sorafenib; Xenograft Model Antitumor Assays | 2017 |